Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques
- PMID: 7892606
- DOI: 10.1126/science.7892606
Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques
Abstract
Adult macaques do not develop disease after infection with a nef deletion mutant of the simian immunodeficiency virus (SIV) and are protected against challenge with pathogenic virus. This finding led to the proposal to use nef-deleted viruses as live, attenuated vaccines to prevent human acquired immunodeficiency syndrome (AIDS). In contrast, neonatal macaques developed persistently high levels of viremia after oral exposure to and SIV nef, vpr, and negative regulatory element (NRE) deletion mutant. Severe hemolytic anemia, thrombocytopenia, and CD4+ T cell depletion were observed, indicating that neither nef nor vpr determine pathogenicity in neonates. Because such constructs have retained their pathogenic potential, they should not be used as candidate live, attenuated virus vaccines against human AIDS.
Comment in
-
Attenuated retrovirus vaccines and AIDS.Science. 1995 Nov 17;270(5239):1218-9; author reply 1220-2. Science. 1995. PMID: 7502051 No abstract available.
-
Attenuated retrovirus vaccines and AIDS.Science. 1995 Nov 17;270(5239):1219; author reply 1220-2. Science. 1995. PMID: 7502052 No abstract available.
-
Attenuated retrovirus vaccines and AIDS.Science. 1995 Nov 17;270(5239):1219; author reply 1220-2. Science. 1995. PMID: 7502053 No abstract available.
-
Attenuated retrovirus vaccines and AIDS.Science. 1995 Nov 17;270(5239):1219-20; author reply 1220-2. Science. 1995. PMID: 7502054 No abstract available.
Similar articles
-
Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques.Nat Med. 1999 Feb;5(2):194-203. doi: 10.1038/5557. Nat Med. 1999. PMID: 9930868
-
Live attenuated SIV vaccines are not effective in a postexposure vaccination model.AIDS Res Hum Retroviruses. 1997 May 1;13(7):593-9. doi: 10.1089/aid.1997.13.593. AIDS Res Hum Retroviruses. 1997. PMID: 9135877 Clinical Trial.
-
Simian immunodeficiency virus promoter exchange results in a highly attenuated strain that protects against uncloned challenge virus.J Virol. 2004 Feb;78(3):1080-92. doi: 10.1128/jvi.78.3.1080-1092.2004. J Virol. 2004. PMID: 14722263 Free PMC article.
-
Live attenuated AIDS viruses as vaccines: promise or peril?Immunol Rev. 1999 Aug;170:135-49. doi: 10.1111/j.1600-065x.1999.tb01335.x. Immunol Rev. 1999. PMID: 10566148 Review.
-
Protective immunity induced by live attenuated simian immunodeficiency virus.Curr Opin Immunol. 1998 Aug;10(4):436-43. doi: 10.1016/s0952-7915(98)80118-0. Curr Opin Immunol. 1998. PMID: 9722920 Review.
Cited by
-
Increased Virus Replication and Cytotoxicity of Non-pathogenic Simian Human Immuno Deficiency Viruses-NM-3rN After Serial Passage in a Monkey-Derived Cell Line.Ann Med Health Sci Res. 2013 Jan;3(1):55-61. doi: 10.4103/2141-9248.109490. Ann Med Health Sci Res. 2013. PMID: 23634331 Free PMC article.
-
Coreceptor phenotype of natural human immunodeficiency virus with nef deleted evolves in vivo, leading to increased virulence.J Virol. 2002 Jul;76(14):6966-73. doi: 10.1128/jvi.76.14.6966-6973.2002. J Virol. 2002. PMID: 12072497 Free PMC article.
-
HIV vaccines in infants and children.Paediatr Drugs. 2005;7(5):267-76. doi: 10.2165/00148581-200507050-00001. Paediatr Drugs. 2005. PMID: 16220994 Review.
-
Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239.J Virol. 2005 Jun;79(12):7707-20. doi: 10.1128/JVI.79.12.7707-7720.2005. J Virol. 2005. PMID: 15919923 Free PMC article.
-
A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease.J Virol. 2005 Dec;79(24):15356-67. doi: 10.1128/JVI.79.24.15356-15367.2005. J Virol. 2005. PMID: 16306607 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials